Concepedia

Yangzhong Tang

YT

Statistics

Publications

8

Citations

343

H-Index

8

Active since

2008

Affiliations

University of California, Berkeley(Current)

Harvard University

Center for Systems Biology

Yangzhong Tang is an author at University of California, Berkeley specializing in molecular oncology, oncology, and cancer pharmacology.

ORCID

Publications per year

2008–2025

8

Publications

8

Quantitative live imaging of cancer and normal cells treated with Kinesin-5 inhibitors indicates significant differences in phenotypic responses and cell fate

James D. Orth, Yangzhong Tang, Clement T. Loy et al. · Molecular Cancer Therapeutics · 2008 · 118 citations · Full text

, , +17

CB-6644 Is a Selective Inhibitor of the RUVBL1/2 Complex with Anticancer Activity

Victoria A. Assimon, Yangzhong Tang, Jesse D. Vargas et al. · ACS Chemical Biology · 2019 · 98 citations

, , +11

Targeting acute myeloid leukemia dependency on VCP-mediated DNA repair through a selective second-generation small-molecule inhibitor

Blandine Roux, Camille Vaganay, Jesse D. Vargas et al. · Science Translational Medicine · 2021 · 55 citations · Full text

, , +17

WRN inhibition leads to its chromatin-associated degradation via the PIAS4-RNF4-p97/VCP axis

Fernando Rodríguez-Pérez, Dean E. Natwick, Lauren Schiff et al. · Nature Communications · 2024 · 18 citations · Full text

, , +16

Oblique line scan illumination enables expansive, accurate and sensitive single-protein measurements in solution and in living cells

Amine Driouchi, Mason Bretan, Brynmor J. Davis et al. · Nature Methods · 2025 · 16 citations · Full text

, , +17

1–5 of 8